Canada Markets closed

CareDx, Inc (1K9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
59.00-1.00 (-1.67%)
At close: 9:47AM CEST
Full screen
Previous Close60.00
Open59.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range59.00 - 59.00
52 Week Range40.43 - 80.36
Volume3
Avg. Volume16
Market Cap3.071B
Beta (5Y Monthly)0.63
PE Ratio (TTM)N/A
EPS (TTM)-0.23
Earnings DateMay 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks

    Earnings Preview: CareDx (CDNA) Q3 Earnings Expected to Decline

    CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    CareDx’s AlloSure Demonstrates Better Accuracy Than Current Standards of Care in Independent Kidney Transplant Study

    Landmark Longitudinal Study in Over 1,000 Transplant Patients Confirms AlloSure More Accurately Measures Organ HealthSOUTH SAN FRANCISCO, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today congratulated OrganX on the completion of a landmark longitudinal study that shows

  • GlobeNewswire

    CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement

    Eledon to use AlloSure to help assess the efficacy of AT-1501 in the prevention of rejection in Eledon’s upcoming renal transplantation trialsSOUTH SAN FRANCISCO, Calif. and IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, and Eledon Pharmaceuticals, Inc. (“Eledon”) (Na